TREM2 promotes hippocampal neurogenesis through regulating microglial M2 polarization in APP/PS1 mice

Xiao-Qian Peng1, Hong-Song Guo1, Xiao Zhang1

  • 1Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.

PubMed

Insights

Upregulating Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) in Alzheimer

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Mutations in TREM2 increase Alzheimer's disease risk.
  • TREM2 activation may reduce amyloid plaques and tau pathology.
  • TREM2's impact on neurogenesis remains unclear.

Purpose of the Study:

  • Investigate TREM2's effects on hippocampal neurogenesis.
  • Examine TREM2's role in microglial M2 polarization.
  • Assess TREM2's therapeutic potential in Alzheimer's models.

Main Methods:

  • Used lentivirus vectors to modulate TREM2 expression in APP/PS1 mice and BV2 cells.
  • Cultured neural stem cells (NSCs) with conditioned medium from BV2 cells.
  • Analyzed microglial polarization markers (CD206, CD16/32, CD86) and neurotrophic factors (BDNF).
  • Investigated PI3K/Akt signaling pathway activation and effects of PI3K inhibitor LY294002.

Main Results:

  • TREM2 upregulation partially restored NSC proliferation and neuronal numbers in APP/PS1 mice, improving cognition.
  • TREM2 shifted microglia towards M2 polarization, increasing CD206, BDNF, and anti-inflammatory factors.
  • TREM2 activation of PI3K/Akt pathway was crucial for these beneficial effects.
  • Inhibition of PI3K abolished TREM2's positive impact on microglia and NSCs.

Conclusions:

  • TREM2 upregulation promotes microglial M2 polarization via the PI3K/Akt pathway.
  • This enhances hippocampal neurogenesis and cognitive function in an Alzheimer's mouse model.
  • TREM2 represents a potential therapeutic target for neurodegenerative diseases.

Related Concept Videos